Decitabine for Injection 50mg

Decitabine for Injection 50mg Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Decitabine for Injection 50mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

• Decitabine for Injection 50mg
  Each vial contains:
  Decitabine……………………50mg
  Excipients…………………….q.s.

THERAPEUTIC INDICATION:

Decitabine is used to treat myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood cells). This medicine reduces the growth of cancer cells.

DIRECTION OF USE:

For Intravenous infusion only.

Reconstitution: Reconstitute with 10 ml of Sterile Water for Injection USP.

CAUTION & WARNING:

CAUTION: This injection should not be used if it contains visible particulate matter after reconstitution.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an Oncologist/ Cancer Hospital only.
CAUTION: This is potent Cytotoxic agent. Use only after reading the directions on the pack insert.
WARNING: Cytotoxic Agent: Handle with care.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.
Discard any unused solution.
Keep out of the reach of the children.

STORAGE & DOSAGE:

Storage: Store vials at 20°C to 25°C (68° to 77° F); excursions permitted between 15°C to 30°C (59° to 86° F) [See USP Controlled Room Temperature].
Dosage: As directed by an Oncologist.

Why Taj Pharmaceuticals?

Elevate your healthcare journey with Taj Pharmaceuticals and experience the exceptional quality of Decitabine for Injection. As a critical treatment for blood disorders such as myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), Decitabine is administered with utmost precision and care when you choose Taj Pharmaceuticals. At Taj Pharmaceuticals, we are driven by a commitment to improving patient outcomes. Our extensive research and development efforts ensure that every vial of Decitabine meets the highest standards of safety and efficacy. We invest in cutting-edge technologies and adhere to stringent quality control measures, providing you with a product you can trust. Beyond the medication itself, Taj Pharmaceuticals offers a patient-centered approach. We understand the challenges and complexities of managing blood disorders, and our dedicated support extends to both healthcare providers and patients. With Taj Pharmaceuticals, you’re not just receiving a pharmaceutical product; you’re gaining a partner in your journey towards better health. Make the choice that countless healthcare professionals and patients trust. Choose Taj Pharmaceuticals for Decitabine for Injection and experience the assurance of excellence in every aspect of your treatment. Your well-being is our top priority, and together, we can make a difference in the battle against blood disorders.

What is Decitabine for Injection and its uses:

Decitabine for Injection is a crucial medication primarily utilized in the treatment of specific blood disorders, notably myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). As a chemotherapy drug, Decitabine plays a pivotal role in addressing conditions characterized by irregularities in blood cell production.

Uses in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Decitabine holds significant therapeutic value in the management of myelodysplastic syndromes, a group of disorders characterized by inefficient blood cell production within the bone marrow. By promoting more effective blood cell production, Decitabine aids in enhancing blood cell counts and has the potential to delay the progression of MDS to more severe forms or even leukemia. Furthermore, Decitabine finds application in specific cases of acute myeloid leukemia, a swiftly advancing cancer affecting the blood and bone marrow. Particularly for older adults who may be less tolerant of more aggressive chemotherapy regimens, Decitabine can serve as an effective treatment option.

How does Decitabine for Injection Work:

Decitabine for Injection is a medication designed to address the abnormal DNA methylation processes commonly found in cancer cells, particularly in conditions like myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Its mechanism of action is centered on disrupting these irregular DNA methylation patterns to restore normalcy in cell growth and differentiation. In healthy cells, DNA methylation is a natural process where methyl groups are added to specific DNA regions. This process serves as a regulator of gene expression, determining which genes are active or inactive. It plays a pivotal role in controlling cell growth and differentiation, maintaining cellular health. However, in cancer cells, including those in MDS and AML, aberrant DNA methylation patterns are often observed. These abnormalities lead to the silencing of genes that are essential for controlling cell growth and differentiation, contributing to uncontrolled cell proliferation and a failure to mature into normal blood cells.

Decitabine steps in as a DNA methyltransferase inhibitor, disrupting the abnormal DNA methylation processes in cancer cells. Upon entering the body, Decitabine becomes integrated into the DNA of the cancer cells during cell division. This integration triggers a disturbance in the irregular methylation patterns, initiating a process called DNA demethylation. The result of this intervention is the reactivation of silenced genes responsible for regulating cell growth and differentiation. With these genes back in action, cancer cells regain their ability to govern their growth and maturation. Consequently, the uncontrolled proliferation of cancer cells is reduced, and the development of more mature and normal blood cells is promoted. Decitabine for Injection operates at the molecular level to rectify the abnormal DNA methylation patterns present in cancer cells, ultimately restoring control over cell growth and differentiation. This mechanism of action holds promise in slowing down or halting the progression of blood disorders like MDS and AML, ultimately leading to improved patient outcomes. Decitabine is typically administered under the supervision of healthcare professionals to ensure its efficacy and to monitor any potential side effects.

Benefits of Decitabine for Injection:

Decitabine for Injection offers a range of significant benefits in the treatment of specific blood disorders, primarily myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). One of its foremost advantages is its proven effectiveness as a treatment option. Decitabine can significantly improve blood cell counts and, importantly, slow down the progression of these diseases.

Moreover, Decitabine stands out as a viable choice for older adults who may face challenges in tolerating more aggressive chemotherapy regimens. Its combination of effectiveness and tolerability makes it a valuable therapeutic option, particularly for this patient demographic.

In the realm of MDS, Decitabine offers the potential to delay the progression of the condition to more severe forms or even leukemia. This translates to extended time and an improved quality of life for patients, emphasizing its role in enhancing overall well-being.

Decitabine’s mechanism of action is also worth noting, as it involves the normalization of DNA methylation patterns within cancer cells. This process leads to the reactivation of genes responsible for controlling cell growth and differentiation, thereby restoring normalcy in blood cell production.

Side Effects of Decitabine for Injection:

Conversely, like many medical treatments, Decitabine may entail certain side effects that necessitate consideration. One common occurrence is a reduction in white blood cell, red blood cell, and platelet counts. This may elevate the risk of infections, anemia, and bleeding, necessitating regular blood tests to monitor these levels throughout treatment.

Fatigue or weakness can also be experienced as a result of Decitabine treatment, although the degree may vary among individuals. Similarly, some patients may encounter nausea and vomiting during or following Decitabine infusion, with medications available to mitigate these symptoms.

Decitabine treatment can occasionally lead to fever, digestive issues like diarrhea or constipation, and skin rash or itching. Liver function may also be impacted, typically monitored through blood tests. Pain or discomfort at the injection site and swelling in the hands, ankles, or feet due to fluid retention are additional potential side effects.

It’s crucial to underscore the rare occurrence of severe allergic reactions to Decitabine, which may present as breathing difficulties, facial or throat swelling, and hives. Immediate medical attention is imperative if such symptoms manifest.

While the benefits of Decitabine are substantial, patients and healthcare providers must remain vigilant about potential side effects. Healthcare teams closely monitor patients during treatment and adjust plans as necessary to effectively manage side effects. Decisions regarding Decitabine use are typically tailored to individual patient conditions, weighing the potential benefits against the risks of side effects. Open and informed discussions with healthcare providers are encouraged to facilitate well-informed treatment decisions.

Frequently Asked Questions About Decitabine for Injection:

Certainly, here are some frequently asked questions (FAQs) about Decitabine for Injection:

1. What is Decitabine for Injection, and what is its primary use?

Decitabine for Injection is a medication used primarily to treat certain blood disorders, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).

2. How does Decitabine work in treating blood disorders?

Decitabine works by disrupting abnormal DNA methylation processes in cancer cells, particularly in MDS and AML. This disruption helps restore normal cell growth and differentiation.

3. Who is a suitable candidate for Decitabine treatment?

Decitabine is often considered for individuals with MDS or AML, especially those who may not tolerate more aggressive chemotherapy regimens. It is also used in older adults for whom other treatments may not be as suitable.

4. How is Decitabine administered?

Decitabine is typically administered through intravenous (IV) infusion by a healthcare professional. The specific dosage and treatment schedule are determined by the healthcare provider based on the patient’s condition.

5. What are the potential side effects of Decitabine for Injection?

Common side effects include low blood cell counts (white blood cells, red blood cells, and platelets), fatigue, nausea, vomiting, and fever. Other possible side effects include digestive issues, skin rash, liver function changes, and fluid retention. Severe allergic reactions are rare but possible.

6. Is Decitabine safe for use during pregnancy or breastfeeding?

Decitabine is not safe during pregnancy and should be avoided. Effective contraception is recommended during treatment. It is not typically used during breastfeeding, as it may pass into breast milk and harm the infant.

7. How long does Decitabine treatment typically last?

The duration of Decitabine treatment varies depending on the patient’s specific condition and response to the treatment. It may be administered in cycles, with rest periods between cycles.

8. Can Decitabine completely cure blood disorders like AML or MDS?

Decitabine may help improve blood cell counts and slow down the progression of these disorders, but it may not always result in a complete cure. The effectiveness of treatment varies from patient to patient.

9. Are there any specific precautions or dietary restrictions during Decitabine treatment?

Patients should follow their healthcare provider’s instructions closely during Decitabine treatment. Precautions may include monitoring for infection, managing side effects, and maintaining good hydration and nutrition.

10. What should I do if I experience severe side effects or allergic reactions during Decitabine treatment?

If you experience severe side effects or allergic reactions, such as difficulty breathing or swelling of the face or throat, seek immediate medical attention. Inform your healthcare provider about any adverse reactions as soon as possible.

These FAQs provide a foundational understanding of Decitabine for Injection, but individual patient circumstances and treatment plans may vary. Patients are encouraged to engage in open and thorough discussions with their healthcare provider to address specific questions and concerns regarding their treatment.

As Decitabine for Injection Exporters; We can cater to export business queries from the following geographies. We are exporting our Decitabine for Injection product in the Following Countries-

Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine

GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, and Iraq.

African Countries: Nigeria, Tanzania, Sudan, Zambia, Benin, Angola, Liberia

Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam

Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius

Decitabine for Injection Regulatory Documents:

• Certificate of Analysis (COA)
• Method of Analysis (MOA)
• Stability Data (Accelerated stability / Long-term stability / Zone 4b)
• CTD Dossier / ACTD Dossiers / eCTD Dossiers
• Certificate of Pharmaceuticals Product (COPP)
• Free Sale Certificate (FSC)

Contact the most reliable manufacturer of Decitabine for Injection, Taj Pharmaceuticals Limited, to get bulk quantities at a reasonable price.

To Place Orders:

Direct line: +91 8448 444 095 / WhatsApp +91 74 0000 9975 / 74 0000 9976
E-Mail: info@tajpharma.com 
Toll free: 1-800-222-434 / Toll free: 1-800-222-825
General EPA BX: +91 22 2637 4592 / +91 22 2637 4593
Fax No: +91 22 2634 1274